Evangelos Cholongitas

39PUBLICATIONS
54CO-AUTHORS
Metabolic medicinePredictive and prognostic markersPharmacogenomicsRegenerative medicine (incl. stem cells)Food sustainability
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (39)

|May 27, 2026
Evaluation of Sarcopenic Obesity in Patients with MASLD.

|May 27, 2026
Relative Trunk Adipopenia Is Associated with the Severity of Liver Disease and Outcome in Patients with Cirrhosis.

|Dec 30, 2025
The Influence of Glucagon-like Peptide-1 Receptor Agonists and Other Incretin Hormone Agonists on Body Composition.

Lampros Chrysavgis, Niki Gerasimoula Mourelatou, Maria-Evangelia Koloutsou

|Jul 29, 2025
Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs): A Pan-Steatotic Liver Disease Treatment?

Lampros Chrysavgis, Niki-Gerasimoula Mourelatou, Evangelos Cholongitas

|Jun 16, 2025
HERACLIS_BLV_D: Increasing Response Rates During 2-Year Bulevirtide Real-Life Therapy in Chronic Hepatitis D.

Margarita Papatheodoridi, Vasilios Sevastianos, Kalliopi Zachou

|May 19, 2025
Key Points and Future Directions from the 2024 Chinese Guidelines for Fatty Liver Disease.

Maria Tampaki, Evangelos Cholongitas

Pageof 7

Frequent Collaborators

17 joint publications

Georgios Papatheodoridis

8 joint publications

Lampros G Chrysavgis

4 joint publications

Dimitrios S Karagiannakis

3 joint publications

Sofia Tsitsou